Evidence map›Paper›PMID 25624877›Full record

ArticleEcancermedicalscience2014

Report from the OECI Oncology Days 2014.

Wh van Harten, G Stanta, G Bussolati, P Riegman, G Hoefler, Kf Becker, G Folprecht, M Truini, J Haybaeck, R Buiga and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ecancermedicalscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Wh van HartenThe Netherlands Cancer Institute, Amsterdam,The Netherlands.
G StantaDepartment of Medical Sciences, University of Trieste, Trieste, Italy.
G BussolatiDepartment of Medical Sciences, University of Torino, Torino, Italy.
P RiegmanErasmus Medical Centre, Rotterdam, The Netherlands.
G HoeflerJohannes Haybaeck, Institute of Pathology, Medical University of Graz, Graz, Austria.
Kf BeckerInstitute of Pathology, Technische Universität München, München, Germany.
G FolprechtUniversity Cancer Centre, University Hospital Carl Gustav Carus, Dresden, Germany.
M TruiniIRCCS AOU San Martino/IST National Cancer Institute of Genoa, Genoa, Italy.
J HaybaeckJohannes Haybaeck, Institute of Pathology, Medical University of Graz, Graz, Austria.
R BuigaThe Oncology Institute "Prof. Dr. Ion Chircuţă", Cluj-Napoca, Romania.
M DonoIRCCS AOU San Martino/IST, National Cancer Institute of Genoa, Italy.
A BaggHematology, University of Pennsylvania, PA, USA.
Ja López GuerreroFundación Instituto Valenciano de Oncología, València, Spain.
S ZupoIRCCS AOU San Martino/IST, National Cancer Institute of Genoa, Italy.
F LemareClinical Pharmacy Department, Gustave Roussy Comprehensive Cancer Centre, Villejuif, France.
F de LorenzoEuropean Cancer Patient Coalition, Brussels, Belgium.
N GoedbloedThe Netherlands Cancer Institute, Amsterdam,The Netherlands.
D RazaviInstitut Jules Bordet et Université Libre de Bruxelles, Clinique de Psycho-Oncologie et des Soins Supportifs, Brussels, Belgium.
J LöveyNational Institute of Oncology, Budapest, Hungary.
Pa CadariuThe Oncology Institute "Prof. Dr. Ion Chircuţă", Cluj-Napoca, Romania.
Ga RollandiDepartment of Radiology, E.O. Ospedali Galliera, Mura della Cappuccine, Genoa, Italy.
F PaparoDepartment of Radiology, E.O. Ospedali Galliera, Mura della Cappuccine, Genoa, Italy.
M PierottiIRCCS Fondazione Istituto Nazionale Tumori Milan, Milan, Italy.
T CiuleanuThe Oncology Institute "Prof. Dr. Ion Chircuţă", Cluj-Napoca, Romania.
P De PaoliCentro di Riferimento Oncologico, IRCCS, Aviano, Italy.
G WeinerUniversity of Iowa, IA, USA.
M SaghatchianMedical Oncology Department, Gustave Roussy Comprehensive Cancer Centre, Villejuif, France.
Claudio LombardoOrganisation of the European Cancer Institutes, C/o SOS Europe, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2014 OECI Oncology Days was held at the 'Prof. Dr. Ion Chiricuta' Oncology Institute in Cluj, Romania, from 12 to 13 June. The focus of this year's gathering was on developments in personalised medicine and other treatment advances which have made the cost of cancer care too high for many regions throughout Europe.

Indexed as

accreditationcomprehensive cancer centresdesignationorganisationpersonalized medicine

Identifiers

PMID25624877
PMCPMC4303612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.